4//SEC Filing
SMITH J. JEFFERSON 4
Accession 0000950170-25-034010
CIK 0001357874other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:00 PM ET
Size
9.7 KB
Accession
0000950170-25-034010
Insider Transaction Report
Form 4
SMITH J. JEFFERSON
Chief Research Officer
Transactions
- Sale
Common Stock
2025-03-04$4.91/sh−154$756→ 87,805 total - Exercise/Conversion
Restricted Stock Units
2025-03-03−519→ 0 total→ Common Stock (519 underlying) - Exercise/Conversion
Common Stock
2025-03-03+519→ 87,959 total
Holdings
- 7,931(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the vesting of Restricted Stock Units ("RSUs") on March 3, 2025.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The sales were effected pursuant to a Rule 10b5-1 plan adopted on April 25, 2024. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F4]On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001770169
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:00 PM ET
- Size
- 9.7 KB